Abstract:Abstract Purpose To assess the efficacy and safety of a novel ophthalmic viscosurgical device-free (OVD-free) method for posterior chamber phakic intraocular lens (PIOL) implantation in myopic eyes. Methods In this retrospective cohort study, the medical records of myopic eyes that underwent PIOL (Implantable Collamer Lens, ICL) implantation for myopia correction at the Eye Hospital of Wenzhou Medical University between May 2015 and March 2017 were reviewed. A total of 49 eyes with complete data that met follow up requirements (2 h, 1 day, 1 week, 3 months postoperatively) were recruited. Based on the surgical techniques used, the eyes were divided into the OVD-free method group and the standard method group. The clinical data, including intraocular pressure (IOP), corrected distance visual acuity (CDVA) and spherical equivalent (SE), at each follow-up were collected for comparison. Endothelial cell loss and complications were also investigated. Results Twenty-one eyes received the standard method, and 28 eyes received the OVD-free method. A rise in IOP > 22 mmHg at 2 h was noted in 14 eyes (66.7%) in the standard group and none (0%) in the OVD-free group ( p < 0.001). The rise in IOP from baseline was significantly higher at 2 h in the standard group (10.5 ± 5.2 mmHg vs. 2.2 ± 3.3 mmHg, difference: 8.3, 95% CI 5.8 to 10.8; p < 0.001). There was a significant difference in the time course of LogMAR CDVA changes between the two groups ( p = 0.047). The LogMAR CDVA was significantly better in the OVD-free method group compared to the standard group at 1 day (− 0.076, 95% CI − 0.134 to − 0.018; p = 0.012), 1 week (− 0.071, 95% CI − 0.135 to − 0.007; p = 0.03), but not at 3 months (− 0.046, 95% CI − 0.107 to 0.015; p = 0.134). There was no significant difference in the time course of SE changes between the two groups ( p = 0.471; p = 0.705). In the OVD-free group, mean endothelial cell loss was 4.6% at 3 months (2522 ± 281 vs. 2407 ± 226 cells/mm 2 , difference: -115, 95% CI − 295 to 65; p = 0.187). No complications were reported in both groups except for the early IOP elevation in the standard group during the observation period. Conclusions The OVD-free method is safe and efficient for ICL implantation. It can be a safer method of ICL implantation compared to the standard method in that it completely eliminates ophthalmic viscoelastic devices-related complications without causing additional complications.

A novel ophthalmic viscosurgical device-free phakic intraocular lens implantation makes myopic surgery safer

Clinical outcomes of a modified ophthalmic viscosurgical device-free implantable collamer lens implantation

Safety of implantable Collamer lens implantation without ophthalmic viscosurgical device: A retrospective cohort study

Posterior chamber collagen copolymer phakic intraocular lens with a central hole for moderate-to-high myopia: First experience in China.

One-year Observation of Safety of Implantable Collamer Lens V4c Implantation Without Using an Ophthalmic Viscosurgical Device

Safety of EVO ICL Implantation With an Ophthalmic Viscosurgical Device-Free Technique in the Early 24 h After Surgery

Posterior Chamber Phakic Intraocular Lens Implantation for High Myopia

Clinical observations of EVO-ICL implantation with single incision without viscoelastic agent

Long-Term Ultrasound Biomicroscopy Observation of Position Changes of A Copolymer Posterior Chamber Phakic Intraocular Lens

One-step Viscoelastic Agent Technique for ICL V4c Implantation for Myopia.

Observation on Changes of Anterior Chamber and Chamber Angle Structures after Posterior Chamber Phakic Intraocular Lens Implantation by Ultrasound Biomicroscopy

[Posterior chamber phakic intraocular lens for correction of extreme myopia]

Clinical Investigation of Iris-Claw Phakic Intraocular Lens Implantation for High Myopia

Efficacy and Safety of Implantable Collamer Lens V4c Implantation in 1,834 Myopic Eyes for 1 Year of Follow-up

Implantation of iris-claw phakic anterior chamber intraocular lenses for the correction of severe myopia]

Implantable Collamer Lens Versus Iris-Fixed Phakic Intraocular Lens Implantation To Correct Myopia: A Meta-Analysis

Clinical Observation of a Novel Technique: Transscleral Suture Fixation of a Foldable 3-Looped Haptics One-Piece Posterior Chamber Intraocular Lens Implantation Through Scleral Pockets with Intact Conjunctiva

6/0 prolene double-flanged IOL sutureless scleral fixation with a 27-gauge needle for intraocular lens surgery

[Mid-long term follow-up results in correction of extreme myopia by posterior chamber phakic intraocular lens]

Intraocular Implantable Collamer Lens with a Central Hole Implantation: Safety, Efficacy, and Patient Outcomes

A comparative study of two phakic posterior chamber implantable lenses